Morgan Stanley initiates Kymera Therapeutics stock with Overweight rating

Related
As if Texas floods weren’t enough, now there’s a fast-approa...
4 minutes ago
0
Genpact declares $0.17 dividend
5 minutes ago
0
E2open Parent Holdings Non-GAAP EPS of $0.05 beats by $0.01,...
6 minutes ago
0
Gladstone Commercial declares $0.10 dividend
7 minutes ago
0
Stock markets rise to new records thanks to the one-two punc...
14 minutes ago
0
Wells Fargo plans to end money-losing Bilt credit-card pact ...
15 minutes ago
0
Vor Bio appoints Sandy Mahatme as CFO
17 minutes ago
0
WD-40 GAAP EPS of $1.54 beats by $0.14, revenue of $156.91M ...
18 minutes ago
0
Agree Realty declares $0.256 dividend
18 minutes ago
0
Simply Good Foods signals 3% organic sales growth and mid-si...
21 minutes ago
0
Jane Birkin’s original Birkin bag breaks records with $10 mi...
21 minutes ago
0
Rare earth stocks rally as MP Materials seals 'transformativ...
26 minutes ago
0
Nike replaces Converse CEO with head of men's division -- Bl...
30 minutes ago
0
Why Mark Zuckerberg’s AI talent spending spree is no guarant...
34 minutes ago
0
Nvidia CEO Jensen Huang meets with Trump at White House
38 minutes ago
0
Top 25 tactical trades or ‘out-of-consensus’ ideas for earni...
40 minutes ago
0
SA Asks: Will Tesla's board try to rein in Elon Musk?
42 minutes ago
0
Apple intends to release slate of updated products in early ...
42 minutes ago
0
Omega Healthcare tenant Genesis gets stalking horse bid from...
51 minutes ago
0
Cognition soars 35% after positive FDA meeting on Alzheimer'...
56 minutes ago
0
Trending
Popular
© FBT Company 2025. All rights are reserved